Clinical Activity of Agenus' Immunotherapy in Combatting Colorectal Cancer Among Young Americans
Thursday, 13 June 2024, 06:28
![https://store.livarava.com/a649af6b-2968-11ef-ab75-0d95d4a28fb2.jpg](https://store.livarava.com/a649af6b-2968-11ef-ab75-0d95d4a28fb2.jpg)
Clinical Activity of Agenus' Immunotherapy
Agenus' novel immunotherapy demonstrates strong clinical activity against a deadly form of colorectal cancer that is on the rise in Americans under 50, offering new hope in treatment.
- Important: The study highlights the effectiveness of this innovative approach in combating a growing health issue.
- Findings: The research shows promising results in addressing colorectal cancer in a younger demographic.
Do you want to advertise here? Contact us